HBK INVESTMENTS L P

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1011443 DALLAS, TX

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$0

New position

Shares Held

2,950,000

first reported quarter

Ownership

2.55%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HBK INVESTMENTS L P holds $861,082,950 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	6,825,000	$482,186,250
2	APGE	Apogee Therapeutics, Inc.	2,850,000	$378,280,500
3	HUMA	Humacyte, Inc.	790,000	$616,200
4	CPRX	Catalyst Pharmaceuticals, Inc.	2,820,302	$0
5	NUVL	Nuvalent, Inc.	3,483,100	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	2,950,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.